Portal Vein Thrombosis due to Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) after Covid Vaccination with ChAdOx1 nCoV-19

Ultraschall Med 2021; 42(05): 551-552
DOI: 10.1055/a-1579-9303

Case Report

Pfortaderthrombose bei immunthrombotischer Thrombozytopenie (VITT) nach Impfung gegen SARS-CoV-2 mit Adenovirus-basiertem Vakzin (ChAdOx1 nCoV-19)

Deike Strobel

Internal medicine I, University of Erlangen, Germany

,

Sophie Haberkamp

Internal medicine I, University of Erlangen, Germany

,

Sebastian Zundler

Internal medicine I, University of Erlangen, Germany

References
1 Greinacher A, Thiele T, Warkentin TE. et al. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med 2021;
2 Schultz NH, Sørvoll IH, Michelsen AE. et al. Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination. N Engl J Med 2021;
3 Graf T, Thiele T, Klingebiel R. et al. Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-COVID-19-adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein thrombosis. J Neurol 2021; 22: 1-3
4 Chawla YK, Bodh V. Portal Vein Thrombosis. J Clin Exp Hepatol 2015; 5: 22-40
5 https://www.rki.de/DE/Content/Infekt/Impfen/Materialien/Downloads-COVID-19-Vektorimpfstoff/Aufklaerungsbogen-Englisch